Further, neither the relationship between SRF and patient activation nor the activation characteristics of individuals with different SRF profiles among patients with breast cancer undergoing chemotherapy have been comprehensively explored, and understanding these relationships will be crucial for improving patient SRF, increasing their activation and promoting high quality cancer control and treatment. Here, SRF is linked to breast carcinoma.